Inventor · disambiguated record
Norihito Tokunaga
Also filed as: TOKUNAGA NORIHITO
27 granted patents·10 pending applications·151 citations·filing 1997–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO30TAKEDA PHARMACEUTICAL2TOYO KASEI KOGYO CO LTD2FUKUMOTO SHOJI1TSUKAMOTO TETSUYA1
Top patents by PatentIndex Score
37 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0395US11028048B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 8, 2021·8 cites·9 claims
- 0494US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0593US11292766B2Substituted piperidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 5, 2022·6 cites·10 claims
- 0689US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0788US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 0888US9527807B2Sulfonamide derivative and use thereofFUKUMOTO SHOJI·Filed 2012·Granted Dec 27, 2016·26 cites·11 claims
- 0987US11713311B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 1, 2023·1 cites·8 claims
- 1087US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 1186US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1285US11186565B2Aromatic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 30, 2021·3 cites·10 claims
- 1385US9187453B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Nov 17, 2015·12 cites·6 claims
- 1484US12281073B2Substituted piperidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 1584US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1684US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1780US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 1880US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1980US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 2079US9637483B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted May 2, 2017·4 cites·6 claims
- 2177US11230541B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 25, 2022·2 cites·12 claims
- 2277US5744612AProcess for preparation of 5- substituted tetrazolesTOYO KASEI KOGYO CO LTD·Filed 1997·Granted Apr 28, 1998·22 cites·4 claims
- 2376US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2475US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2572US2022081399A1Substituted piperidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2670US6040454AProcess for preparation of a 1-(tetrazolylbiphenylmethyl)-imidazole derivativeTOYO KASEI KOGYO CO LTD·Filed 1998·Granted Mar 21, 2000·15 cites·5 claims
- 2763US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2855US2025250230A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2953US12077522B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 3, 2024·0 cites·11 claims
- 3053US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 3152US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 3252US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 3351US12448377B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 21, 2025·0 cites·16 claims
- 3451US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 3545US2017174682A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 3642US2016159773A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 3733US2013005710A1Aminopyridine derivativeTSUKAMOTO TETSUYA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norihito Tokunaga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →